pharmacies to tally how often GLP-1 drugs are now being prescribed to children and teens
MOTS-C research indicates improvements in cardiac function, particularly in the context of type 2 diabetes
But the timing of that weekly injection still matters, and the reasoning behind it is worth understanding rather than simply following a rule without knowing why
Our study provided valuable evidence for early clinical interventions and the identification of the risk of gastrointestinal toxicities
If retatrutide and other GLP-1 medications also reduce LDL, it makes them powerful dual-action therapies: not just fighting obesity and diabetes, but also reducing heart disease risk
Other foods are more likely to cause brain fog, body aches, inflammation, sugar cravings